Lonza has launched a new basal and feed medium, specifically developed to drive significant viability and integrity enhancements in protein production The eCHO™ Medium is ideal for use in the manufacture of recombinant proteins for medical use, such as monoclonal antibodies and complex glycoproteins Results demonstrating the performance of the eCHO™ Medium will be presented […]
– Low invasiveness enables single-cell injection of target substances and extraction of intracellular materials – Tokyo, Japan Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired a nanopipette*1 technology that was developed by BioStinger, Inc., a spin-off from the University of California, Santa Cruz. This technology is able to target specific locations inside individual cells, […]
Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services. BELTSVILLE, MD.: REPROCELL Inc. a stem cell and drug discovery company has announced today that they have been selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its portfolio of oncology drugs. The collaboration […]
Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. DARMSTADT, GERMANY License to accelerate research, enable testing and development of new drugs Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR […]
Global leader in liquid nitrogen storage systems expected to support growth, diversify revenue and reduce evo® manufacturing costs Preliminary 2020 revenue guidance of $50 – $56 Million Conference call begins today at 4:30 p.m. Eastern time BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of best-in-class […]
MOUNTAIN VIEW, Calif.–Takara Bio USA, Inc. (TBUSA) announced that its parent company, Takara Bio Inc., has launched the world’s first commercially available small intestinal epithelial cells derived from human induced pluripotent stem cells. The new Cellartis® Intestinal Epithelial Cells (from ChiPSC18) Kit was jointly developed when Takara Bio received a technology transfer from a differentiation induction method […]
Leading immuno-oncology company adopts Genedata Biologics to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies, a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D […]
Nanopore sequencing can now be used for investigating chromatin contacts, to identify genome-wide contacts directly, without amplification. Weill Cornell Medicine and Oxford Nanopore have published a pre-print describing this new technique, and an end-to-end workflow and analysis tools are now available online. Investigating genome architecture Chromatin structure relies on the physical interaction of many genomic loci and investigating the architecture of […]
Agilent Technologies Inc. (NYSE: A) and MGI Tech have signed an agreement to conduct more in-depth cooperation in high throughput sequencing, which will give full play to their respective advantages in laboratory information management and sequencing platforms and provide the industry with a more efficient and reliable high throughput sequencing overall solution. Recently, at the […]
* ORFLO’s cell analysis offering to complement Gemini’s portfolio of cell culture reagents WEST SACRAMENTO, CA – Gemini Bioproducts, LLC (“Gemini”), a leading provider of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), today announced the acquisition of ORFLO Technologies (“ORFLO”), an innovative life sciences instrumentation company. Founded in 2003 […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
